Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01IZE
|
|||
| Former ID |
DIB001163
|
|||
| Drug Name |
Recombinant botulinum toxin vaccine
|
|||
| Synonyms |
RBOT; Recombinant botulinum toxin vaccine (intramuscular formulation); Recombinant botulinum toxin vaccine, Emergent BioSolutions; Botulinum toxin vaccine (recombinant), Emergent BioSolutions; Botulinum toxin vaccine (recombinant), Emergent BioSolutions/Health Protection Agency; Recombinant botulinum toxin vaccine (intramuscular formulation), Emergent BioSolutions/Health Protection Agency
Click to Show/Hide
|
|||
| Indication | Yersinia infection [ICD-11: 1B93; ICD-9: 20] | Phase 2 | [1] | |
| Company |
Dynport vaccine
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | CSC's dynport vaccine company releases results for Phase 2 botulinum vaccine clinical trial. CSC. January 24, 2012. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.